Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL) (C-Term) Peptide

CBL Reactivité: Humain Hôte: Synthetic BP
N° du produit ABIN8096289
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL) (C-Term) Peptide (ABIN8096289)

Antigène

CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))

Origine

Humain

Source

  • 6
Synthetic

Application

Blocking Peptide (BP)
  • Protein Region

    C-Term

    Fonction

    CBL Peptide - C-terminal region

    Séquence

    GEGNLAAAHA NTGPEESENE DDGYDVPKPP VPAVLARRTL SDISNASSSF
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti- CBL Antibody (ARP35761_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))

    Sujet

    Background Information: This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder.

    Alternative Symbols: CBL2, NSLL, C-CBL, RNF55, FRA11B

    Poids moléculaire

    99 kDa

    ID gène

    867

    NCBI Accession

    NP_005179

    UniProt

    P22681
Vous êtes ici:
Chat with us!